Aggrastat GPIIb/IIIa blocker data

Merck presented data from two trials at the Amerian College of Cardiology meeting

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE